Surprisingly we found that the expression of chemokine receptor CXCR4, which promotes hematopoiesis, cell migration/homing and bone marrow retention [51], was reduced in different immune subsets from COVID-19 patients of our considered cohort. This evidence concerns the gene CXCR4 and COVID-19.